Debt Restructuring

The cannabis giant upsizes its credit facility by CAD $15M, signaling strong lender confidence and fueling its ambitious global expansion plans.

The housing giant's tender offer for CAS notes reflects a strategic move to manage debt in a changing interest rate landscape. What does it mean for investors?

The diagnostics firm has 180 days to boost its market value after a Nasdaq warning, placing immense pressure on its turnaround and high-stakes biosensor plans.

U.S. Steel's subsidiary launches a tender offer to clear legacy debt, a strategic move to streamline operations and unlock flexibility under new ownership.

The REIT is offering a high 9.75% yield for new notes, but investors who refuse the swap could see their current protections vanish. A critical choice looms.

A massive Mojave water bank project secures a key federal loan application, promising drought relief for California but reigniting a long-running environmental battle.

Bausch Health heads to a key finance conference to address investor concerns over its massive debt, upcoming patent cliffs, and future strategic direction.

Appili Therapeutics lands a $40M deal to fight fungal threats, but with cash reserves low and loans due, can its science outpace its financial pressures?

The satellite firm unveils a complex debt shuffle and $1B capital raise, fueling its network vision while sending its stock tumbling on dilution fears.

A massive financing deal for A Crane Rental highlights the crucial role of private credit in rebuilding America's infrastructure and industrial base.

DFR Gold secures $1.2M in insider loans, pushing total debt to $4.5M. The funds aim to fast-track its Burkina Faso gold project, but is it a vote of confidence or a sign of financial strain?

After posting strong preliminary Q4 results, Harvard Bioscience unveils a new strategy to lead the booming organoid and translational science market.

The French retailer accepts a criminal conviction for market manipulation but will fight civil damages, adding another layer to its urgent restructuring.

The private jet operator posted record revenue with fewer planes, achieving its first-ever quarter of positive Adjusted EBITDA in a major turnaround.

A new report reveals a stark drop in profitability, but owners remain surprisingly optimistic, fueling a massive surge in demand for capital.

The tech giant's savvy financial moves are set to save $27M annually, extending maturities and freeing up cash for future innovation and growth.

Liberty Energy seeks $500M in convertible notes, a complex financial move to repay debt, fund its diversification, and manage shareholder dilution.

Facing default, The Cannabist Company secures a short-term forbearance, highlighting a systemic liquidity crisis threatening the US cannabis industry.

With a major investment plan underway, Tallinna Vesi's upcoming 2025 financial report is set to reveal the impact on profits, dividends, and Tallinn's future.

After teetering on the brink, Poxel SA has secured court approval for a complex recovery plan, offering a lifeline for its innovative metabolic drug pipeline.